Skip to main content

Tumors Molecular and Genomic Mechanism and Diagnostics of CNS Tumors

  • Chapter
  • First Online:
Surgical Neuro-Oncology

Abstract

This chapter delves into the molecular and genomic mechanisms underlying a diverse spectrum of CNS tumors. Specifically, the chapter covers gliomas, ependymomas, medulloblastomas, atypical teratoid/rhabdoid tumors, pineal region tumors, meningiomas, CNS solitary fibrous tumors/hemangiopericytomas, hemangioblastomas, vestibular schwannomas, and craniopharyngiomas. Through a series of multiple-choice questions, this chapter facilitates a deeper understanding of the molecular and genomic foundations of CNS tumors and further explores the clinical characteristics of specific molecular subtypes of these tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  1. Routman DM, Raghunathan A, Giannini C, Mahajan A, Beltran C, Nagib MG, Nageswara Rao AA, Skrypek MM, Laack NNI. Anaplastic ependymoma and posterior fossa grouping in a patient with H3K27ME3 loss of expression but chromosomal imbalance. Adv Radiat Oncol. 2019;4(3):466–72.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kristensen BW, Priesterbach-Ackley LP, Petersen JK, Wesseling P. Molecular pathology of tumors of the central nervous system. Ann Oncol. 2019;30(8):1265–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Spiegl-Kreinecker S, Lötsch D, Neumayer K, Kastler L, Gojo J, Pirker C, Pichler J, Weis S, Kumar R, Webersinke G, Gruber A, Berger W. TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma. Neuro Oncol. 2018;20(12):1584–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Koczkodaj D, Muzyka-Kasietczuk J, Chocholska S, Podhorecka M. Prognostic significance of isochromosome 17q in hematologic malignancies. Oncotarget. 2021;12(7):708–18.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Park SH, Won J, Kim SI, Lee Y, Park CK, Kim SK, Choi SH. Molecular testing of brain tumor. J Pathol Transl Med. 2017;51(3):205–23.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Shan FY, Castro E, Sybenga A, Mukherjee S, Wu E, Fung K, Li T, Fonkem E, Huang JH, Rao A. Molecular diagnostics and pathology of major brain tumors. In: Primary intracranial tumors. IntechOpen; 2019.

    Google Scholar 

  7. Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Rodriguez FJ, Vizcaino MA, Lin MT. Recent advances on the molecular pathology of glial neoplasms in children and adults. J Mol Diagn. 2016;18(5):620–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Wood MD, Halfpenny AM, Moore SR. Applications of molecular neuro-oncology—a review of diffuse glioma integrated diagnosis and emerging molecular entities. Diagn Pathol. 2019;14(1):29.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Meredith DM, Alexandrescu S. Embryonal and non-meningothelial mesenchymal tumors of the central nervous system—advances in diagnosis and prognostication. Brain Pathol. 2022;32(4):e13059.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Cohen AL, Colman H. Glioma biology and molecular markers. Cancer Treat Res. 2015;163:15–30.

    Article  PubMed  Google Scholar 

  12. Chan KM, Fang D, Gan H, Hashizume R, Yu C, Schroeder M, Gupta N, Mueller S, James CD, Jenkins R, Sarkaria J, Zhang Z. The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression. Genes Dev. 2013;27(9):985–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Yang P, Cai J, Yan W, Zhang W, Wang Y, Chen B, Li G, Li S, Wu C, Yao K, Li W, Peng X, You Y, Chen L, Jiang C, Qiu X, Jiang T, CGGA Project. Classification based on mutations of TERT promoter and IDH characterizes subtypes in grade II/III gliomas. Neuro Oncol. 2016;18(8):1099–108.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Masliah-Planchon J, Machet MC, Fréneaux P, Jourdain A, Mortemousque I, Raïs KA, Ballet S, Jouvet A, Figarella-Branger D, Delattre O, Bourdeaut F. SMARCA4-mutated atypical teratoid/rhabdoid tumor with retained BRG1 expression. Pediatr Blood Cancer. 2016;63(3):568–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Atallah, O. et al. (2024). Tumors Molecular and Genomic Mechanism and Diagnostics of CNS Tumors. In: Hoz, S.S., et al. Surgical Neuro-Oncology. Springer, Cham. https://doi.org/10.1007/978-3-031-53642-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-53642-7_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-53641-0

  • Online ISBN: 978-3-031-53642-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics